TwentyNCIt concept

https://www.ordremk.fr/wp-content/uploads/2024/03/avis-cno-n2024-03.pdf
2024
France
scientific and technical information
Medical Order
Andorra
Relative Value
Sequence of Planned Assessment Schedule
Karnofsky Performance Status 20
counseling
Permutation
Physical Therapist
Application
mars
Brace
achievement
Computer Application
Lansky Performance Status 20
March
orthotic devices
attention
Twenty
Application
judgment
physical therapists
Council
Neither Agree or Disagree
Counseling
masseur
Application Method of Administration

---
https://www.srlf.org/article/20-ans-davancees-nouveau-souffle-bpco
2024
France
critical appraisal or critical reading
Heart Murmur
Newar Language
chronic obstructive lung disease, nos
Karnofsky Performance Status 20
pulmonary disease, chronic obstructive
Twenty
Chronic Obstructive Pulmonary Disease
blast
New Lesion Identification
Copeptin Measurement
Lansky Performance Status 20
COPP Regimen
Stooping
COPD Assessment Test Questionnaire
Autonomic Nervous System
Blowing Heart Murmur
Andorra
How Worried
Cyclophosphamide/Vincristine/Prednisone/Bleomycin Regimen

---
https://www.ordremk.fr/wp-content/uploads/2024/03/avis-cno-n2024-02.pdf
2024
France
scientific and technical information
Tumor Progression Absent After Initial Treatment
Routine Cytogenetics Were not Completed
Intervention Not Given for Kawasaki Disease
Negation
Counseling
ATRX Gene Mutation Negative
No Response to Intervention for Kawasaki Disease
judgment
Chemotherapy Not Received
ROS1 Rearrangement Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
No History of Neonatal Complication
Chief Complaint Not Caused by Trauma
student, nos
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Cancer History Absent
Any Metastatic Diagnosis Absent
Paraneoplastic Syndrome is Not Present
NON Mouse
Chemical/Occupational Exposure Absent
Council
Radiation History Negative
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
New Disease is not Multifocal
Evidence of Disease Absent after Completion of Therapy
Use of Smokeless Tobacco at Time of Diagnosis Negative
mars
First Degree Family History Cancer Negative
No History of Non-Cardiac Surgery
History of Medical Treatment Absent
IV Anesthesia was not Administered
Additional Molecular Studies Were Not Performed
Medication Not Taken
Family History of Stomach Cancer Absent
No History of Kawasaki Disease
Additional Surgery for New Tumor Event Absent
Preoperative IV Opiates were not Administered
First Degree Family History of Primary Brain Tumor Negative
No History of Rheumatic Fever
New Tumor Event After Initial Treatment Absent
Additional Surgery for New Metastatic Tumor Event Was Not Performed
ERBB2 Mutation Analysis Was Not Performed
Permutation
IDH Family Mutation Analysis Was Not Performed
Twenty
Sequence of Planned Assessment Schedule
Preoperative IV Sedation was Not Administered
NRAS Mutation Analysis Was Not Performed
Karnofsky Performance Status 20
TP53 Mutation Analysis Was Not Performed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Physician Diagnosed Diabetes Absent
Another Form of Birth Control was not Used
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ATRX Mutation Analysis Was Not Performed
Caffeine Not Routinely Consumed
Other Preoperative IV Medications were not Administered
BRAF Mutation Analysis Was Not Performed
IDH Family Wildtype
Neither Case or Control Status
Unemployed
Nitric Oxide Measurement
counseling
Andorra
Lymph Node Dissection Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
BRAF Rearrangement Analysis Was Not Performed
EGFR Amplification Analysis Was Not Performed
No History of Myopathy
Norway
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
10q23/PTEN Locus Deletion Analysis Was Not Performed
Nitric Oxide
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Foster Relative
Radiation Therapy Not Received
KIT Mutation Analysis Was Not Performed
No History of Gestational Complication
Hypertension Absent
Preoperative IV Antacids were not Administered
History of Colorectal Cancer Negative
Intercurrent Illness is Absent at Onset of Chief Complaint
Adjuvant Post-operative Chemotherapy Was Not Administered
Chief Complaint was Not Witnessed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Patient was not Postmenopausal with no Prior Oophorectomy
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Not Lost to Follow-Up
RET Rearrangement Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
students
Tumor Reoccurrence Absent After Initial Treatment
Preoperative IV Antiemetics were not Administered
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Therapeutic Ionizing Radiation to Head History Absent
1p/19q Deletion Analysis Was Not Performed
No History of Congenital Heart Disease
Medical Order
Patient was Not Previously Evaluated for Current Chief Complaint
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Has No Sibling
MGMT Promoter Methylation Testing Was Not Performed
March
Neither Agree or Disagree
MET Mutation Analysis Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Regional Anesthesia was not Administered
SDH Complex Mutation Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Minor Criteria for Rheumatic Heart Disease Not Present
ALK Rearrangement Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
Local Anesthesia Agents were not Administered
PTEN Mutation Analysis Was Not Performed
PTEN Gene Mutation Negative
No Known History of Alcohol Use
EGFR Gene Amplification Negative
No Known History of Illicit Drug Use
NF1 Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
Documentation Absent
Fluorescence In Situ Hybridization Was Not Performed
physical therapy specialty
Lansky Performance Status 20
EGFR Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Additional Immunohistochemistry Was Not Performed

---
https://drees.solidarites-sante.gouv.fr/240716_ER_AccompagnementPersonnesHandicapees
2024
France
journal article
Finnish Language
Finland
End
Karnofsky Performance Status 20
socialism
Social
limited function/disability nos
End Time
Twenty
Severity One Out of Four
ENG wt Allele
Autonomic Nervous System
Lansky Performance Status 20
handicap
Andorra
Additional
Persons with Disabilities
Endoglin
Disabled Population
social support

---
https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000049517243
2024
France
legislation
health
Data Systems
Nano
Device System
Twenty
Data Security
N
Relative Value
delivery of health care
MATCH Arm EAY131-N
computer security
Signal to Noise Ratio
Projected
Drug Delivery System Category
data security
Neither Agree or Disagree
Tumor to Normal
Drug Delivery System
Discontinue
Lansky Performance Status 20
judgment
national security
No
Projection
N Category
Karnofsky Performance Status 20
Newton
July
Andorra

---
https://www.inspq.qc.ca/publications/3495
2024
Canada
public health guidelines
vaccinia virus
aged
quebec
Schedule
vaccination
preventive immunization/medication
age under 20 years
Karnofsky Performance Status 20
viral vaccines
elderly person, nos
Calendar
Human Papillomavirus
immunization schedule
Human Papillomavirus Viruses
aged, 80 and over
Autonomic Nervous System
Schedule
papillomaviridae
human papillomavirus, nos
Vaccinia Virus
Elderly
Lansky Performance Status 20
Twenty
personhood
Andorra
vaccinia virus

---
https://www.inspq.qc.ca/publications/3387
2023
Canada
technical report
breast neoplasms
Program
screening for cancer
Lansky Performance Status 20
Breast Cancer Screening
Autonomic Nervous System
Karnofsky Performance Status 20
Sample Statistic
statistics
cancer screening
Twenty
Experiment Object
breast cancer
Schedule
Andorra
Scheduled
statistics as topic
Statistics
early detection of cancer

---